The development and application of technology to improve the work flow and ease of use of molecular diagnostics were the founding principles of Lumora and this was a key reason behind the ERBA mannheim acquisition. The team at ERBA Molecular have invented and patented a number of key technologies that simplify and reduce the cost of molecular diagnostic testing. At the heart of the company is our detection system, BART (Bioluminescent Assay in Real Time) which enables this key principle
ERBA Molecular has developed a range of proprietary technologies that have produced an Integrated molecular isothermal technology in which the individual components of Sample Prep, Amplification and Real-Time Detection all work seamlessly together to provide optimal performance.
The technology described above as well as our Next Generation Quantification application (NGQ) or Digital BART are described in more detail in the links below.